Market Exclusive

Analyst Activity – J P Morgan Chase & Co Reiterates Neutral on GlaxoSmithKline PLC (NYSE:GSK)

Analyst Ratings For GlaxoSmithKline PLC (NYSE:GSK)

Today, J P Morgan Chase & Co reiterated its Neutral rating on GlaxoSmithKline PLC (NYSE:GSK).

There are 2 sell ratings, 6 hold ratings, 6 buy ratings on the stock.

The current consensus rating on GlaxoSmithKline PLC (NYSE:GSK) is Hold (Score: 2.29) with a consensus target price of $43.50 per share, a potential 7.09% upside.

Some recent analyst ratings include

Dividend information for GlaxoSmithKline PLC (NYSE:GSK)

GlaxoSmithKline PLC (NYSE:GSK) pays an annual dividend of Community Ranking: with a yield of 4.87% and an average dividend growth of -3.10% based on a 3 Year Average.

Dividend History for GlaxoSmithKline PLC (NYSE:GSK)

Recent Insider Trading Activity For GlaxoSmithKline PLC (NYSE:GSK)
GlaxoSmithKline PLC (NYSE:GSK) has insider ownership of 10.00% and institutional ownership of 9.31%.

Recent Trading Activity for GlaxoSmithKline PLC (NYSE:GSK)
Shares of GlaxoSmithKline PLC closed the previous trading session at with shares trading hands.

Exit mobile version